*THE DESIGN OF THE PRODUCTION OF BUTANOL WITH THE PILOT PLANT TEST VERIFICATION
Public support
Provider
Ministry of Industry and Trade
Programme
TIP
Call for proposals
TIP 1 (SMPO2009/01)
Main participants
—
Contest type
VS - Public tender
Contract ID
FR-TI1/218
Alternative language
Project name in Czech
*NÁVRH TECHNOLOGIE VÝROBY BIOBUTANOLU A JEJÍ OVĚŘENÍ V POLOPROVOZNÍM MĚŘÍTKU
Annotation in Czech
*Výzkum a vývoj technologie přípravy butanolu jako biopaliva 2. generace. Zvládnutí technologie procesu, testování v laboratorním a poloprovozním měřítku, matematické modelování a projektování celé technologie.
Scientific branches
R&D category
AP - Applied research
CEP classification - main branch
CI - Industrial chemistry and chemical engineering
CEP - secondary branch
EI - Biotechnology and bionics
CEP - another secondary branch
—
OECD FORD - equivalent branches <br>(according to the <a href="http://www.vyzkum.cz/storage/att/E6EF7938F0E854BAE520AC119FB22E8D/Prevodnik_oboru_Frascati.pdf">converter</a>)
20401 - Chemical engineering (plants, products)<br>20402 - Chemical process engineering<br>20801 - Environmental biotechnology<br>20802 - Bioremediation, diagnostic biotechnologies (DNA chips and biosensing devices) in environmental management<br>20803 - Environmental biotechnology related ethics<br>20901 - Industrial biotechnology<br>20902 - Bioprocessing technologies (industrial processes relying on biological agents to drive the process) biocatalysis, fermentation<br>20903 - Bioproducts (products that are manufactured using biological material as feedstock) biomaterials, bioplastics, biofuels, bioderived bulk and fine chemicals, bio-derived novel materials<br>30401 - Health-related biotechnology<br>30402 - Technologies involving the manipulation of cells, tissues, organs or the whole organism (assisted reproduction)<br>30403 - Technologies involving identifying the functioning of DNA, proteins and enzymes and how they influence the onset of disease and maintenance of well-being (gene-based diagnostics and therapeutic interventions [pharmacogenomics, gene-based therapeutics])<br>30404 - Biomaterials (as related to medical implants, devices, sensors)<br>30405 - Medical biotechnology related ethics<br>40401 - Agricultural biotechnology and food biotechnology<br>40402 - GM technology (crops and livestock), livestock cloning, marker assisted selection, diagnostics (DNA chips and biosensing devices for the early/accurate detection of diseases) biomass feedstock production technologies, biopharming<br>40403 - Agricultural biotechnology related ethics
Completed project evaluation
Provider evaluation
U - Uspěl podle zadání (s publikovanými či patentovanými výsledky atd.)
Project results evaluation
The goals and material contents of the project under subject were fulfilled within the defined extent and terms.
Solution timeline
Realization period - beginning
Mar 1, 2009
Realization period - end
Jun 30, 2012
Project status
U - Finished project
Latest support payment
May 11, 2011
Data delivery to CEP
Confidentiality
C - Předmět řešení projektu podléhá obchodnímu tajemství (§ 504 Občanského zákoníku), ale název projektu, cíle projektu a u ukončeného nebo zastaveného projektu zhodnocení výsledku řešení projektu (údaje P03, P04, P15, P19, P29, PN8) dodané do CEP, jsou upraveny tak, aby byly zveřejnitelné.
Data delivery code
CEP13-MPO-FR-U/02:2
Data delivery date
Jul 14, 2014
Finance
Total approved costs
10,189 thou. CZK
Public financial support
7,477 thou. CZK
Other public sources
0 thou. CZK
Non public and foreign sources
2,712 thou. CZK